Get the Stockscreener App
3.50
12.50%
-0.50
Pre-market:
3.81
0.31
+8.86%
Traws Pharma Inc Stock (TRAW) Forecast
The Traws Pharma Inc (TRAW) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5451, representing a -84.43% decrease from the current price of $3.50. The highest analyst price target is $0.6088, and the lowest is $0.4814.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRAW Price Target
Average 0.4853
(-86.13% Downside)
Is Traws Pharma Inc (TRAW) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.24 | Buy |
| STOCH(9,6) | 4.6914 | Buy |
| STOCHRSI(14) | 5.6618 | Buy |
| MACD(12,26) | -0.8257 | Sell |
| ADX(14) | 23.33 | Neutral |
| William %R | -96.78 | Buy |
| CCI(14) | -125.18 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.311
Sell
|
5.0781
Sell
|
| MA20 |
6.45
Sell
|
5.8844
Sell
|
| MA50 |
7.0396
Sell
|
6.4577
Sell
|
| MA100 |
6.021
Sell
|
6.994
Sell
|
| MA200 |
8.5508
Sell
|
8.9207
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TRAW could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on TRAW, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.24 indicates that TRAW is oversold. This indicates that TRAW price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 4.6914 indicates that TRAW is oversold. This indicates that TRAW price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.6618 indicates that TRAW is oversold. This suggests that TRAW price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.33 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -125.18 indicates that TRAW is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term TRAW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Traws Pharma Inc financial reports and earnings history, Traws Pharma Inc (TRAW) stock could reach $0.0758 by 2030, $1.3661 by 2040 and $2.6663 by 2050. See the projected annual prices until 2050 of the Traws Pharma Inc stock below:
- Traws Pharma Inc (TRAW) is expected to reach an average price of $0.74 in 2035, with a high prediction of $0.721 and a low estimate of $0.7443. This indicates an $-78.86% rise from the last recorded price of $3.50.
- Traws Pharma Inc (TRAW) stock is projected to chart a bullish course in 2040, with an average price target of $1.39, representing an $-60.29% surge from its current level. The forecast ranges from a conservative $1.3871 to a sky-high $1.3661.
- Our analysts predict Traws Pharma Inc (TRAW) to jump -40.59% by 2045, soaring from $2.0298 to an average price of $2.0792, potentially reaching $2.0113. While $2.0298 is the low estimate, the potential upside is significant.
- Traws Pharma Inc (TRAW) stock is expected to climb by 2050, reaching an average of $2.6749, a $-23.57% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.6663 and $2.6725, respectively, highlighting the market's uncertainty.
Traws Pharma Inc Stock (TRAW) Year by Year Forecast
Traws Pharma Inc Stock (TRAW) Price Forecast for 2025
Traws Pharma Inc Stock (TRAW) is expected to reach an average price of $0.5053 in 2025, with a high prediction of $0.6288 and a low estimate of $0.3818. This indicates an -85.56% fall from the last recorded price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.5409 | $0.4814 | $0.6088 | -84.55% |
| April, 2025 | $0.5351 | $0.4715 | $0.5988 | -84.71% |
| May, 2025 | $0.5252 | $0.4615 | $0.5888 | -85.00% |
| June, 2025 | $0.5152 | $0.4516 | $0.5788 | -85.28% |
| July, 2025 | $0.50 | $0.4416 | $0.5688 | -85.71% |
| August, 2025 | $0.49 | $0.4316 | $0.5488 | -86.00% |
| September, 2025 | $0.48 | $0.4217 | $0.5388 | -86.29% |
| October, 2025 | $0.4214 | $0.4017 | $0.5288 | -87.96% |
| November, 2025 | $0.4115 | $0.3918 | $0.5188 | -88.24% |
| December, 2025 | $0.4416 | $0.3818 | $0.5088 | -87.38% |
Traws Pharma Inc Stock (TRAW) Price Forecast for 2026
The predicted value for Traws Pharma Inc (TRAW) in 2026 is set at an average of $0.3756. Estimates vary from a peak of $0.4988 to a trough of $0.2523, indicating an -89.27% surge from the present price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4317 | $0.3719 | $0.4988 | -87.67% |
| February, 2026 | $0.4218 | $0.3619 | $0.4888 | -87.95% |
| March, 2026 | $0.4119 | $0.3519 | $0.4788 | -88.23% |
| April, 2026 | $0.4054 | $0.342 | $0.4688 | -88.42% |
| May, 2026 | $0.3954 | $0.332 | $0.4588 | -88.70% |
| June, 2026 | $0.3854 | $0.322 | $0.4488 | -88.99% |
| July, 2026 | $0.37 | $0.3121 | $0.4388 | -89.43% |
| August, 2026 | $0.36 | $0.3021 | $0.4188 | -89.71% |
| September, 2026 | $0.3019 | $0.2822 | $0.4088 | -91.37% |
| October, 2026 | $0.2919 | $0.2722 | $0.3988 | -91.66% |
| November, 2026 | $0.282 | $0.2623 | $0.3888 | -91.94% |
| December, 2026 | $0.3126 | $0.2523 | $0.3788 | -91.07% |
Traws Pharma Inc Stock (TRAW) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Traws Pharma Inc (TRAW) is $0.2458, with a high forecast of $0.3688 and a low forecast of $0.1228. This indicates an -92.98% decrease from the last price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3027 | $0.2423 | $0.3688 | -91.35% |
| February, 2027 | $0.2928 | $0.2324 | $0.3588 | -91.64% |
| March, 2027 | $0.2856 | $0.2224 | $0.3488 | -91.84% |
| April, 2027 | $0.2756 | $0.2125 | $0.3388 | -92.12% |
| May, 2027 | $0.2656 | $0.2025 | $0.3288 | -92.41% |
| June, 2027 | $0.25 | $0.1925 | $0.3188 | -92.86% |
| July, 2027 | $0.24 | $0.1826 | $0.2988 | -93.14% |
| August, 2027 | $0.23 | $0.1726 | $0.2888 | -93.43% |
| September, 2027 | $0.1724 | $0.1527 | $0.2788 | -95.07% |
| October, 2027 | $0.1624 | $0.1427 | $0.2688 | -95.36% |
| November, 2027 | $0.1525 | $0.1328 | $0.2588 | -95.64% |
| December, 2027 | $0.1836 | $0.1228 | $0.2488 | -94.75% |
Traws Pharma Inc Stock (TRAW) Price Forecast for 2028
In 2028, Traws Pharma Inc (TRAW) is projected to reach an average price of $0.121, with a high projection of $0.2388 and a low estimate of $0.00324. This indicates an -96.54% fall from the last price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1737 | $0.1128 | $0.2388 | -95.04% |
| February, 2028 | $0.1637 | $0.1029 | $0.2288 | -95.32% |
| March, 2028 | $0.1559 | $0.0929 | $0.2188 | -95.55% |
| April, 2028 | $0.1459 | $0.0829 | $0.2088 | -95.83% |
| May, 2028 | $0.13 | $0.073 | $0.1988 | -96.29% |
| June, 2028 | $0.12 | $0.063 | $0.1788 | -96.57% |
| July, 2028 | $0.11 | $0.0531 | $0.1688 | -96.86% |
| August, 2028 | $0.0528 | $0.0331 | $0.1588 | -98.49% |
| September, 2028 | $0.0429 | $0.0232 | $0.1488 | -98.78% |
| October, 2028 | $0.0329 | $0.0132 | $0.1388 | -99.06% |
| November, 2028 | $0.0645 | $0.00324 | $0.1288 | -98.16% |
| December, 2028 | $0.0546 | $0.00672 | $0.1188 | -98.44% |
Traws Pharma Inc Stock (TRAW) Price Forecast for 2029
The 2029 price forecast for Traws Pharma Inc Stock (TRAW) is $0.0544 on average, with a high prediction of $0.1088 and a low estimate of $0.000000. This represents an -98.45% decrease from the previous price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0551 | $0.00147 | $0.1088 | -98.42% |
| February, 2029 | $0.0551 | $0.0114 | $0.0988 | -98.43% |
| March, 2029 | $0.048 | $0.00716 | $0.0888 | -98.63% |
| April, 2029 | $0.0394 | $0.000000 | $0.0788 | -98.87% |
| May, 2029 | $0.000000 | $0.01 | $0.0688 | -100.00% |
| June, 2029 | $0.01 | $0.0225 | $0.0488 | -99.71% |
| July, 2029 | $0.02 | $0.0324 | $0.0388 | -99.43% |
| August, 2029 | $0.0767 | $0.0423 | $0.0288 | -97.81% |
| September, 2029 | $0.0867 | $0.0522 | $0.0262 | -97.52% |
| October, 2029 | $0.0546 | $0.0621 | $0.046 | -98.44% |
| November, 2029 | $0.0646 | $0.0719 | $0.056 | -98.16% |
| December, 2029 | $0.0745 | $0.0818 | $0.0659 | -97.87% |
Traws Pharma Inc Stock (TRAW) Price Forecast for 2030
Traws Pharma Inc Stock (TRAW) is expected to reach an average price of $0.1433 in 2030, with a high forecast of $0.1949 and a low forecast of $0.0917. This signifies an -95.91% decrease from the last price of $3.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0838 | $0.0917 | $0.0758 | -97.61% |
| February, 2030 | $0.0979 | $0.11 | $0.0857 | -97.20% |
| March, 2030 | $0.1078 | $0.12 | $0.0957 | -96.92% |
| April, 2030 | $0.1178 | $0.13 | $0.1056 | -96.63% |
| May, 2030 | $0.13 | $0.14 | $0.1155 | -96.29% |
| June, 2030 | $0.14 | $0.151 | $0.1254 | -96.00% |
| July, 2030 | $0.1962 | $0.1609 | $0.1354 | -94.39% |
| August, 2030 | $0.2062 | $0.1708 | $0.1453 | -94.11% |
| September, 2030 | $0.2162 | $0.1807 | $0.1552 | -93.82% |
| October, 2030 | $0.1837 | $0.1906 | $0.1751 | -94.75% |
| November, 2030 | $0.1936 | $0.2005 | $0.185 | -94.47% |
| December, 2030 | $0.2035 | $0.2104 | $0.1949 | -94.19% |
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):